Page 6 - Edwardc Holmes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Delaying 2nd doses of COVID-19 vaccines has benefits, but effects depend on immunity
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Covid variants story can t be used to keep us oppressed
conservativewoman.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from conservativewoman.co.uk Daily Mail and Mail on Sunday newspapers.
Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and the potential for evolution of viral escape from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a Princeton University and McGill University study published March 9 in the journal
Science.
Several countries including the United Kingdom and Canada have stated that they will delay second doses of COVID-19 vaccines in response to supply shortages, but also in an attempt to rapidly increase the number of people immunized.
Spacing COVID-19 vaccine doses has benefits, but longer-term outcomes depend on robust immunity
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
E-Mail
Heidelberg/Germany, 14 December 2020 - Molecular markers in the blood shown to be predictive of severe COVID-19 outcomes resulting from SARS-CoV-2 coronavirus infection have been identified in a study by a Chinese research team. The study results extend understanding of the pathophysiology and clinical progress of COVID-19 with potential for identifying early during the course of infection which individuals are most at risk of developing severe conditions and requiring hospital care.
In addition to pneumonia and septic syndrome, a smaller proportion of patients have also developed severe gastrointestinal and/or cardiovascular symptoms as well as neurological manifestations after SARS-COV-2 infection. This is possible because the angiotensin-converting enzyme 2 (ACE 2) receptor used by SARS-COV-2 for cell entry is found in other organs beside the lungs, including the heart, liver, kidney, pancreas, small intestines and also the CNS (Central Nervous System), especially the g